Evidence map›Paper›PMID 40512252›Full record

ArticleJournal of neurology2025

DAGLA autoantibody experience at Mayo Clinic.

Nisa Vorasoot, Cigdem Isitan-Alkawadri, Bharat Pillai, Ramona Miske, Divyanshu Dubey, Michael Gilligan, Stefanie Hahn, John Mills, Sean J Pittock, Anastasia Zekeridou and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nisa VorasootDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Cigdem Isitan-AlkawadriDepartment of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Bharat PillaiDepartment of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ramona MiskeInstitute for Experimental Immunology, Affiliated with EUROIMMUN Medizinische Labordiagnostika AG, Seekamp 31, 23560, Luebeck, Germany.
Divyanshu DubeyDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Michael GilliganDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Stefanie HahnInstitute for Experimental Immunology, Affiliated with EUROIMMUN Medizinische Labordiagnostika AG, Seekamp 31, 23560, Luebeck, Germany.
John MillsDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Sean J PittockDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Anastasia ZekeridouDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Andrew McKeonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. McKeon.Andrew@mayo.edu.ORCID http://orcid.org/0000-0001-6856-8143

Funding

Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep PhenotypingR01NS126227 · NINDS · MAYO CLINIC ROCHESTER · PI Andrew McKeon · 2022 to 2026
$1.9M
NINDS NIH HHS R01 NS126227
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40512252
PMCPMC12165888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.